Karuna Sundarapandiyan

Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy

Bernhard Stockmeyer, Michael Dechant, Marjolein van Egmond et al. · The Journal of Immunology · 2000 · 117 citations · Full text

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy

Laura Vitale, Lawrence J. Thomas, Li-Zhen He et al. · Cancer Immunology Immunotherapy · 2018 · 64 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Agonist Cd40 Antibody +7

Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab

Venky Ramakrishna, Karuna Sundarapandiyan, Biwei Zhao et al. · Journal for ImmunoTherapy of Cancer · 2015 · 62 citations · Full text

Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood.

Yashwant M. Deo, Karuna Sundarapandiyan, Tibor Keler et al. · PubMed · 1998 · 61 citations

Tumor Biology, Bispecific Molecules, Cross-linking F +14

Bispecific Molecules Directed to the Fc Receptor for IgA (FcαRI, CD89) and Tumor Antigens Efficiently Promote Cell-Mediated Cytotoxicity of Tumor Targets in Whole Blood

Yashwant M. Deo, Karuna Sundarapandiyan, Tibor Keler et al. · The Journal of Immunology · 1998 · 61 citations · Full text

Cross-linking F, Bispecific Molecules Directed, Immunology +19